October 15, 2026 · SOMA Health Research Team

Does Urolithin A Need to Be Cycled? Continuous vs. On-and-Off Dosing

Cellular Health · Urolithin A
Most human research on Urolithin A used continuous daily dosing — typically 500 to 1,000 mg every day for one to four months — not on-and-off cycles. There is no published evidence that Urolithin A requires cycling or washout periods, because its benefits come from ongoing cellular signaling rather than from a stored reserve.

Key takeaways

  • Every major human trial of Urolithin A used continuous daily dosing, not intermittent cycles.
  • The compound clears from the body within about a day, so steady daily intake is what maintains cellular exposure (HUMAN).
  • Benefits appear to depend on sustained mitophagy signaling — there is no reserve to build up or burn out.
  • No clinical trial has tested cycling or washout schedules, so any cycling protocol is unstudied speculation.
  • If you do pause, there is no known harm or rebound reported — cellular exposure simply returns to baseline.

What does “cycling” a supplement actually mean?

Cycling means taking a supplement for a set stretch of time, then deliberately stopping for a while before resuming. People cycle certain compounds for specific reasons: to limit tolerance (as some do with caffeine), to let a receptor system reset, or simply to take a planned break. The habit is well established in a few categories — but it is often carried over to new supplements by assumption rather than evidence. Urolithin A is a good example of a compound where the cycling question comes up constantly, yet the research points in a clear direction.

To answer it honestly, the right place to look is not supplement folklore but how Urolithin A was actually dosed in the studies that found benefits in the first place.

How was Urolithin A actually dosed in clinical trials?

Across the published human trials, the dosing schedule is strikingly consistent: a fixed dose, taken every single day, for the full length of the study. None of the trials below included a “cycling” arm that paused and restarted.

Study (evidence type) Daily dose Duration Schedule
Andreux et al., Nature Metabolism, 2019 (HUMAN, safety & pharmacokinetics) up to 1,000 mg single dose & 28 days Daily, continuous
Liu et al., Cell Reports Medicine, 2022 (HUMAN RCT) 500 & 1,000 mg 4 months Daily, continuous
Singh et al., JAMA Network Open, 2022 (HUMAN RCT) 1,000 mg 4 months Daily, continuous
Liu et al., J. Int. Soc. Sports Nutrition, 2024 (HUMAN RCT) 500 mg 8 weeks Daily, continuous

In other words, the benefits reported for strength, muscle endurance, and mitochondrial biomarkers were all produced by uninterrupted daily use. The studied protocol is continuous dosing.

Why continuous dosing makes biological sense

Urolithin A does not accumulate in the body

Pharmacokinetic work shows that after you take Urolithin A, it appears in the bloodstream mainly as conjugated forms (glucuronide and sulfate), rises over several hours, and is then cleared — largely within a day (Andreux et al., Nature Metabolism, 2019). It is not stored in a long-term depot the way fat-soluble vitamins can be. That clearance profile is exactly why a steady daily dose is used: each day’s dose refreshes cellular exposure rather than topping up a growing reserve.

The benefit is a signal, not a stockpile

Urolithin A’s best-characterized action is supporting mitophagy — the housekeeping process by which cells identify and recycle worn-out mitochondria so healthier ones can take their place (mechanism described in Ryu et al., Nature Medicine, 2016 and reviewed in D’Amico et al., Trends in Molecular Medicine, 2021). Mitophagy is a continuous, ongoing quality-control process, not a one-time event. A compound that nudges that signaling helps while it is present and fades as it clears. There is no evidence of the receptor desensitization or tolerance that makes cycling useful for stimulants, so the usual rationale for scheduled breaks simply does not apply here.

Is there any reason to cycle Urolithin A?

From the current evidence, there is no physiological reason to cycle it. Human safety data support continuous use for up to four months — the longest trials run so far — with good tolerability (Andreux et al., Nature Metabolism, 2019; Singh et al., JAMA Network Open, 2022). No published study reports a loss of effect over time that a washout would restore.

That said, people sometimes pause for practical reasons: managing cost, taking a break while traveling, or stepping back to reassess whether they want to continue. Those are personal decisions, not biological requirements. If consistency is your goal, a simple once-daily format — like a gummy you take with breakfast — tends to be easier to stick with than a complicated on-off schedule. That is part of why many people prefer SOMA Urolithin A gummies for daily use.

What we still don’t know

Honesty matters here. The longest controlled human trials lasted about four months, so continuous use beyond that horizon has not been formally studied, even though no safety signal has emerged within it. No trial has ever compared daily dosing head-to-head against an intermittent schedule, so we cannot say an every-other-day or weekday-only approach would match daily results — it simply has not been tested. And because the body’s ability to make Urolithin A from food varies by gut-microbiome “converter” status, baseline exposure differs from person to person. These are open questions, not settled facts.

Frequently asked questions

Do I need to take a break from Urolithin A?

There is no evidence that a scheduled break is necessary. Every human trial that found benefits used uninterrupted daily dosing, and no study reports a need for washout periods.

Will Urolithin A stop working if I take it every day?

No published research shows tolerance building to Urolithin A. Its action supports an ongoing cellular process rather than a receptor that desensitizes, so the rationale behind cycling stimulants does not carry over.

Is it safe to take Urolithin A long-term?

Controlled trials up to four months reported good tolerability at 500–1,000 mg daily (Singh et al., JAMA Network Open, 2022). Use beyond that window has not been formally studied, so talk with a healthcare professional about your own situation.

What happens if I stop taking it?

Because Urolithin A clears from the body within about a day and is not stored, cellular exposure simply returns to baseline. No rebound effect has been reported in the literature.

Does the time of day matter more than cycling?

Consistency tends to matter more than timing. Taking the same dose at the same time each day — whenever is easiest to remember — is the pattern the trials used and the one most people can maintain.

SOMA Urolithin A 1,000mg Gummies
SOMA Health

Support your cellular health, every day

SOMA delivers a high-potency 1,000 mg dose of Urolithin A in one simple daily gummy — no guesswork, no converter-status lottery.

Shop SOMA Urolithin A Gummies →

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

← Back to all articles